Abstract
When Alois Alzheimer first discussed his findings about plaques and tangles in dementia at the 1906-7 Psychiatric Convention of the South West German Society in Tubingen there was no discussion and no interest shown. His first attempt to publish the findings was rejected. It was already known at the time dementia results in the biological markers of plaques and tangles. It was Emil Kraepelin, Alois Alzheimer’s supervisor, that pushed for the publication of these observations and later adopted Alzheimer’s eponym for the disease. But this was all about political and not science. The argument was that although these biological markers were common, it was not common among younger people, and hence the need for a new disease.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
